정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1724 | Active, not recruiting | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | COVID-19 | Drug: Dexamethasone injection Drug: placebo Procedure: conventional oxygen Procedure: CPAP Procedure: HFNO Procedure: mechanical ventilation |
Not Applicable | Assistance Publique - Hopitaux de Paris | OTHER | 550 | All | 18 Years | Hopital Bichat - Aphp, Paris, France |
| 1723 | Recruiting | DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia | Pneumonia, Viral | Drug: Dexamethasone | Phase 3 | Hospital Universitario Infanta Leonor, Fundacion para la Investigacion e Innovacion Biomedica del Hospital Universitario Infanta Leonor, Kern Pharma, S.L. | OTHER | 126 | All | 18 Years | Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Clinico San Carlos, Madrid, Spain Hospital Emergencias Enfermera Isabel Zendal, Madrid, Spain |
| 1722 | Recruiting | Dexamethasone for COVID-19 | Covid19 | Drug: Dexamethasone | Phase 4 | University of Oklahoma | OTHER | 300 | All | 18 Years | University of Oklahoma Medical Center, Oklahoma City, Oklahoma, United States |
| 1721 | Terminated | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | Covid-19 | Drug: High-Dose Dexamethasone | Phase 3 | Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno | OTHER | 100 | All | 18 Years | Hospital Universitario Sede Saaveda - IUC CEMIC, Caba, Argentina Hospital Universitario Sede Pombo - IUC CEMIC, Ciudad Autonoma de Buenos Aires, Argentina Sanatorio Sagrado Corazon, Ciudad Autonoma de Buenos Aires, Argentina Clinica Bazterrica, Ciudad Autonoma de Buenos Aires, Argentina |
| 1720 | Terminated | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | COVID-19 | Drug: Dexamethasone and Hydroxychloroquine Drug: Hydroxychloroquine |
Phase 3 | Centre Chirurgical Marie Lannelongue | OTHER | 5 | All | 18 Years ~ 80 Years | Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson, France |
| 1719 | Recruiting | Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 | ARDS | Drug: Dexamethasone Drug: Methylprednisolone |
Phase 3 | Chattogram General Hospital, Health Science Center of Xi'an Jiaotong University | OTHER_GOV | 60 | All | 20 Years ~ 80 Years | Chattogram General Hospital, Chittagong, Bangladesh M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh |
| 1718 | Recruiting | Dietary Supplements for COVID-19 | Covid19 | Drug: Vitamin D3 50,000 IU Dietary Supplement: Vitamin C/Zinc Dietary Supplement: Vitamin K2/D Other: Microcrystalline Cellulose Capsule Other: Medium Chain Triglyceride Oil |
Phase 3 | The Canadian College of Naturopathic Medicine, Ottawa Hospital Research Institute, Vitazan Professional, New Roots Herbal | OTHER | 200 | All | 18 Years | The Centre for Health Innovation, Ottawa, Ontario, Canada |